Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-Cell Response
Cancer Research - United States
doi 10.1158/0008-5472.can-14-0708
Full Text
Open PDFAbstract
Available in full text
Date
June 17, 2014
Authors
Publisher
American Association for Cancer Research (AACR)